Investigational Epstein-Barr Vaccine Trial

AMR Kansas City is conducting an investigational Epstein-Barr vaccine trial for participants ages 18 to 30.

Qualified participants must:

be 18 to 30 years old

be in overall good health

meet other study criteria

Qualified participants will receive all study-related care at no cost. Reimbursement is available up to $2,400.00 for study-related time and travel.

If you're interested in learning more about this trial, you can reach out to AMR today by calling 816-643-4153 or visiting their website at amrkansascity.com for more detailed information.